News

Medscape28m

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

Wall Street sees new obesity pills as priced near Wegovy and Zepbound

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Mounjaro rivals Wegovy and Retatrutide explained as price hiked for millions of users

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...

Stocks to Watch Monday: Novo Nordisk, Soho House, UnitedHealth, Palo Alto

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
Hosted on MSN2h

How to switch from Mounjaro to Wegovy WITHOUT risking side effects or weight gain, reveals top GP

His statement comes as CheqUp, one of the UK's largest providers of weight-loss treatments, reports sales of rival treatment ...

Quit Ozempic or Wegovy? Here’s How Fast the Pounds Can Come Back

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug ...